Alzheimer’s could be prevented by gender-based personalised medicine, study says

Alzheimer’s disease starts in the brain 20 to 30 years before the first signs of memory loss

Alzheimer’s and other forms of dementia affect more than 920,000 people in the UK

A new study has found Alzheimer’s - which disproportionately affects women - could be prevented by gender-based personalised medicine.

The lead author of the study, Dr Richard Isaacson, of Florida Atlantic University, says that women account for two-in-three patients - with incidence twice as high even after accounting for longer lifespans.

"Population-attributable risk models suggest that managing risk factors can prevent up to one-third of dementia cases, highlighting the immense potential that lies in addressing modifiable risk factors,” Dr Isaacson says.